Medtronic has reported late-breaking data from the randomised Evolut Low Risk Trial’s five-year outcomes of the Evolut ...

New research suggests cerebral embolic protection devices do not lower the risk of stroke in patients undergoing ...

Here are the biggest stories out of ACC 2025: Five-year data from the Medtronic Evolut Low Risk Trial confirmed that its ...

Edwards Lifesciences (NYSE:EW) recently announced significant findings at the ACC Annual Scientific Session, showcasing crucial research in the treatment of structural heart disease. This development, ...

As global markets grapple with economic uncertainty and inflation fears, Asian stock markets have shown resilience amid these challenges. For investors interested in smaller or newer companies, penny ...

On Sunday, researchers announced that an experimental drug from Eli Lilly, lepodisiran, reduced levels of Lp (a) by a ...

BACKGROUND: Heart failure with preserved ejection fraction (HFpEF) has become the most prevalent type of heart failure, but ...

ScImage is a nationally recognised Cloud and integrated workflow management platform, with over 1,200 users, specialising in ...

NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Clenbuterol is used by both men and women to lose weight, raises metabolic rate ...